Refreshing results…
CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
UploadCorrecting the drug development paradigm for glioblastoma requires serial tissue sampling
UploadBrain immunology and immunotherapy in brain tumours
Download from www.nature.comMissing publications? Search for publications with a matching author name.